Xenon Pharmaceuticals to collaborate with CDRD

Guest Contributor
November 23, 2009

Burnaby BC-based Xenon Pharmaceuticals Inc has entered into a strategic collaboration with the commercial arm of the Centre for Drug Research and Development (CDRD). Xenon will work with Drug Development Inc (DDI) to advance an early-stage R&D program. Xenon will leverage CDRD and DDI's technical and research strengths to reach certain early-stage R&D milestones and offers an opportunity to showcase DDI's ability to collaborate with the local life sciences and biotech industries. Xenon is a privately held company developing small molecule therapies targeting metabolic, neurological and cardiovascular diseases....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.